Tan Weihong, Huang Weitao, Gu Xiaogang, Zhong Qiu, Liu Bainan, Schwarzenberger Paul
Department of Gynecology, The People's Hospital of Guangxi Province, P. R. of China.
Exp Hematol. 2008 Nov;36(11):1417-27. doi: 10.1016/j.exphem.2008.06.003. Epub 2008 Aug 23.
IL-17F, a member of the interleukin (IL)-17 cytokine family, most closely resembles IL-17A structurally. IL-17A is a potent stimulator of granulopoiesis; its expression is induced in response to microbial challenge. Although IL-17F is considered to be a weak IL-17A analog that is also mediating its effect via IL-17R, its exact role and in vivo functions are unknown. Our goal was to determine the in vivo activity of IL-17F on granulopoiesis as well as on release of granulopoiesis-stimulating downstream cytokines in mice and directly compare its effect to IL-17A.
Murine IL-17A (mIL-17A) or IL-17F (mIL-17F) was expressed in vivo in C57BL6 mice using adenoviral gene transfer technology. Peripheral cell counts were assessed as well as hematopoietic precursors using colony-forming assays at set time points. Downstream cytokines were measured using enzyme-linked immunosorbent assay and reverse transcriptase polymerase chain reaction.
We found mIL-17F to have similar expression kinetics as mIL-17A in splenocytes in vitro and in vivo, following challenge with microbial agents. Overexpression of mIL-17F in vivo resulted in similar neutrophilia and only in slightly reduced myeloid progenitor expansion when compared to mIL-17A. In vivo, there was no difference in releases for granulocyte-macrophage colony-stimulating factor; regulated on activation, normal T expressed and secreted; interferon-inducible protein-10; IL-6; and monocyte chemotactic protein-1 between either cytokine. IL-1A, macrophage inflammatory protein -2 (MIP), KC, and granulocyte colony-stimulating factor expression was approximately half of that seen with mIL-17A.
Both IL-17A and IL-17F are induced by similar stimuli, have similar expression kinetics and despite only minimal in vitro activity for IL-17F, surprisingly they exert similar in vivo bioactivity. IL-17F bioactivity appears to be augmented in vivo through mechanisms that require further investigation.
白细胞介素(IL)-17细胞因子家族成员IL-17F在结构上与IL-17A最为相似。IL-17A是粒细胞生成的强效刺激因子;其表达在受到微生物刺激时被诱导。尽管IL-17F被认为是一种较弱的IL-17A类似物,也通过IL-17R介导其作用,但其确切作用和体内功能尚不清楚。我们的目标是确定IL-17F在小鼠粒细胞生成以及粒细胞生成刺激下游细胞因子释放方面的体内活性,并将其作用与IL-17A直接进行比较。
使用腺病毒基因转移技术在C57BL6小鼠体内表达小鼠IL-17A(mIL-17A)或IL-17F(mIL-17F)。在设定的时间点评估外周血细胞计数以及使用集落形成试验评估造血前体细胞。使用酶联免疫吸附测定和逆转录聚合酶链反应测量下游细胞因子。
我们发现,在体外和体内的脾细胞中,在用微生物制剂刺激后,mIL-17F与mIL-17A具有相似的表达动力学。与mIL-17A相比,mIL-17F在体内的过表达导致类似的中性粒细胞增多,并且仅使髓系祖细胞扩增略有减少。在体内,两种细胞因子之间的粒细胞-巨噬细胞集落刺激因子、活化调节正常T细胞表达和分泌因子、干扰素诱导蛋白-10、IL-6以及单核细胞趋化蛋白-1的释放没有差异。IL-1A、巨噬细胞炎性蛋白-2(MIP)KC和粒细胞集落刺激因子的表达约为mIL-17A的一半。
IL-17A和IL-17F均由相似的刺激诱导,具有相似的表达动力学,尽管IL-17F在体外活性极小,但令人惊讶的是它们在体内发挥相似的生物活性。IL-17F的生物活性似乎通过需要进一步研究的机制在体内增强。